CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said ...

The S&P 500 climbed by 2.8% on Monday, May 12, 2025 as investors reviewed the trade deal between the U.S. and China that ...

Diversified healthcare company CVS Health (NYSE:CVS) announced in Q1 CY2025, with sales up 7% year on year to $94.59 billion.

Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...

The data is the first head-to-head trial comparing the wildly popular medicines, and gives Lilly more firepower as it seeks ...

A measure now on the floor of the Nebraska Legislature would address some practices by intermediaries called pharmacy benefit managers that pharmacists say are harming their businesses.

Boards, Policy & Regulationcategory· May 12, 2025 Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in ... Lilly downplays CVS move to drop Zepbound coverage, shares plunge ...

Even if the order takes effect, it will do nothing to address the root causes of the problem it purports to solve.

Rite Aid's bankruptcy plan, if approved, means that in the coming months all distribution centers will close, and all stores ...

President Trump signed the executive order shortly before 11 a.m. after a press conference in which he and top officials ...